Clinical trial
MRI Guided Brachytherapy for HPV-Associated Cervical and Vaginal Malignancies
NCT03634267 is registered in ClinicalTrials.gov with M.D. Anderson Cancer Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- MRI Guided Brachytherapy for HPV-Associated Cervical and Vaginal Malignancies
- Lead sponsor
- M.D. Anderson Cancer Center
- Phase
- Phase 1
- Overall status
- Terminated
- Start date
- August 3, 2018
- Completion date
- August 26, 2026
- Enrollment
- 26 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
human papillomavirus-related carcinoma, human papillomavirus-related cervical carcinoma, stage ib2 cervical cancer ajcc v8, stage ii cervical cancer ajcc v8, stage ii vaginal cancer ajcc v8, stage iia cervical cancer ajcc v8, stage iia vaginal cancer ajcc v8, stage iia1 cervical cancer ajcc v8, stage iia2 cervical cancer ajcc v8, stage iib cervical cancer ajcc v8, stage iib vaginal cancer ajcc v8, stage iii cervical cancer ajcc v8, stage iii vaginal cancer ajcc v8, stage iiia cervical cancer ajcc v8, stage iiib cervical cancer ajcc v8, stage iva cervical cancer ajcc v8, stage iva vaginal cancer ajcc v8